Viewing Study NCT01741493


Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2026-02-23 @ 4:55 AM
Study NCT ID: NCT01741493
Status: COMPLETED
Last Update Posted: 2017-11-20
First Post: 2012-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rheumatoid Arthritis View
None Methotrexate View
None Tolerability View
None Pharmacokinetics View
None Safety View
None Tofacitinib View